Intrinsa Advisory Cmte. Decision Should Not Affect Dapoxetine, PPD Says

An FDA advisory committee's recommendation against approval of Procter & Gamble's testosterone patch Intrinsa should not impact Johnson & Johnson's premature ejaculation therapy dapoxetine, PPD says

More from Archive

More from Pink Sheet